Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,454 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,230 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06822036 | EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER(ARISTA) | recruiting | N/A | 362 | St. Antonius Hospital GronauOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06851663 | Trop2-targeted immunoPET Imaging of Solid Tumors | recruiting | Phase 2 / Phase 3 | 400 | RenJi HospitalOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT06964412 | The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy | active not recruiting | N/A | 36 | Brigham and Women's HospitalOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07393867 | Androgen-responsive POSLUMA-guided Intra-prostatic Boost(ARPEGGIO) | recruiting | Phase 2 | 23 | Martin T. King, MD, PhDOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07567521 | A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC | recruiting | Phase 1 / Phase 2 | 90 | C Ray TherapeuticsINDUSTRY | 1 | May 29, 2026 | clinicaltrials |
| NCT07614256 | Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction | recruiting | — | 3,000 | Guangxi Medical UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT04514484 | Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV | active not recruiting | Phase 1 | 8 | National Cancer Institute (NCI)NIH | 1 | May 28, 2026 | clinicaltrials |
| NCT06523777 | PRISM: Patient Experiences With PET Imaging in Prostate Cancer(PRISM) | active not recruiting | — | 350 | Yale UniversityOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT07201194 | Holistic Acupuncture for Patients With Chemotherapy Induced Nausea | recruiting | N/A | 90 | Vejle HospitalOTHER | 1 | May 28, 2026 | clinicaltrials |
| NCT04070209 | Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X) | active not recruiting | Phase 2 | 66 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT05806814 | Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer(OU-SCC-EXCITE) | active not recruiting | Phase 1 | 15 | University of OklahomaOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT06904625 | Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer(CAPT CTC) | recruiting | N/A | 54 | Institut Claudius RegaudOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07607990 | Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP | recruiting | N/A | 130 | Zhejiang UniversityOTHER | 1 | May 27, 2026 | clinicaltrials |
| NCT07608419 | Predictors of Nodal and Distant Metastatic Disease Detected by PSMA PET in Treatment-Naïve High-Risk Prostate Cancer: A Czech Multicentre Cohort Study(CZECH-PSMA) | active not recruiting | — | 400 | General University Hospital, PragueOTHER | 0 | May 27, 2026 | clinicaltrials |
| NCT00949819 | Active Surveillance for Cancer of the Prostate (ASCaP)(ASCaP) | recruiting | — | 462 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT02177292 | High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)(SIB) | active not recruiting | N/A | 80 | Medical College of WisconsinOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT03582774 | Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy(PSMA SRT) | active not recruiting | Phase 3 | 193 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT04263025 | AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft | active not recruiting | Phase 2 / Phase 3 | 100 | Hackensack Meridian HealthOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT05496959 | 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study(LUNAR) | active not recruiting | Phase 2 | 93 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT06492122 | Study With [225Ac]Ac-FL-020 in mCRPC Participants(ProTACT) | recruiting | Phase 1 | 50 | Full-Life Technologies UK LimitedINDUSTRY | 4 | May 26, 2026 | clinicaltrials |
| NCT06508567 | Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era(SHAPE-PSMA) | recruiting | N/A | 20 | University Health Network, TorontoOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT06574880 | STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer(STARLiT) | recruiting | Phase 1 / Phase 2 | 45 | Angela Y. Jia, MD PhDOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07045415 | The Effect of Pelvic Floor Muscle Exercises After Radical Prostatectomy | not yet recruiting | N/A | 10 | KTO Karatay UniversityOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT07605936 | Frailty in Older Adults With Prostate Cancer: a Prospective Cohort Study | recruiting | — | 80 | University of LimerickOTHER | 1 | May 26, 2026 | clinicaltrials |
| NCT02799706 | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer(PEGASUS) | active not recruiting | Phase 3 | 885 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | May 22, 2026 | clinicaltrials |
| NCT03151629 | International Registry for Men With Advanced Prostate Cancer (IRONMAN)(IRONMAN) | recruiting | — | 5,000 | Prostate Cancer Clinical Trials ConsortiumOTHER | 15 | May 22, 2026 | clinicaltrials |
| NCT05225428 | Video Education With Result Dependent dIsclosure(VERDI) | recruiting | N/A | 1,020 | Dana-Farber Cancer InstituteOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT05682443 | ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC(PRESERVE-006) | active not recruiting | Phase 1 / Phase 2 | 148 | OncoC4, Inc.INDUSTRY | 1 | May 22, 2026 | clinicaltrials |
| NCT05931419 | High-Risk prostatE Cancer radiatiOn Versus surgERy(RECOVER) | recruiting | — | 837 | Comprehensive Cancer Centre The NetherlandsOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06238479 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors(EXCEED) | active not recruiting | Phase 1 | 490 | Eli Lilly and CompanyINDUSTRY | 7 | May 22, 2026 | clinicaltrials |
| NCT06935097 | Mediterranean Diet Intervention Among Men at LBJ Hospital With Prostate Cancer | enrolling by invitation | N/A | 25 | M.D. Anderson Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07189403 | A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer | recruiting | Phase 1 | 40 | Daiichi SankyoINDUSTRY | 3 | May 22, 2026 | clinicaltrials |
| NCT07240857 | A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer | enrolling by invitation | Early Phase 1 | 18 | Zhejiang UniversityOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07427043 | Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)(ROPES) | recruiting | Phase 3 | 300 | Brigham and Women's HospitalOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07468903 | Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer | recruiting | N/A | 45 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT07495293 | Ultra-hypofractionated Carbon-ion Therapy for Prostate Cancer | not yet recruiting | Phase 1 | 20 | Yonsei UniversityOTHER | 0 | May 22, 2026 | clinicaltrials |
| NCT03987386 | Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate Cancer | active not recruiting | Phase 3 | 186 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT04388852 | DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers | active not recruiting | Phase 1 | 65 | M.D. Anderson Cancer CenterOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT05830838 | Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer(DAPPER) | active not recruiting | N/A | 50 | Mayo ClinicOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07598032 | Comparative Analysis of Immunological Responses to Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer: Elucidating Differential Effects on Immune Function Between Patients With Localized Disease and Those With Metastatic Progression(iCCaRE) | not yet recruiting | Phase 3 | 200 | University of Ilorin Teaching HospitalOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT07196488 | Dyadic Co-learning Intervention for Patients With Prostate Cancer and Their Spouses | recruiting | N/A | 60 | National Taipei University of Nursing and Health SciencesOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT03933670 | Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | recruiting | Phase 2 | 60 | University of California, San FranciscoOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT04399876 | Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer | enrolling by invitation | Phase 1 | 35 | Brigham and Women's HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT06298838 | High-resolution Intra-operative PSMA PET-CT in Prostate Cancer | not yet recruiting | — | 10 | IRCCS San RaffaeleOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT07541911 | A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy(LaserSAFE) | recruiting | N/A | 693 | University College, LondonOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT07592910 | A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy(MOMENT) | not yet recruiting | Phase 2 | 60 | Prostate Cancer Clinical Trials ConsortiumOTHER | 0 | May 18, 2026 | clinicaltrials |
| NCT00544830 | Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer | active not recruiting | Phase 2 | 29 | City of Hope Medical CenterOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT04472338 | Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study | recruiting | — | 450 | University of WashingtonOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT05627219 | Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network | recruiting | — | 30 | Thomas Jefferson UniversityOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06043947 | Survival Monitoring in Russian Cancer Registries(SURVIMON) | active not recruiting | — | 100,000 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 15, 2026 | clinicaltrials |
Data updated 24 days agoSource updated May 29, 2026source: clinicaltrials